LOBE SCIENCES LTD (F:6YX0) — Market Cap & Net Worth

$2.90 Million USD  · €2.48 Million EUR  · Rank #29531

Market Cap & Net Worth: LOBE SCIENCES LTD (6YX0)

LOBE SCIENCES LTD (F:6YX0) has a market capitalization of $2.90 Million (€2.48 Million) as of June 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #29531 globally and #2573 in its home market, demonstrating a -5.66% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying LOBE SCIENCES LTD's stock price €0.03 by its total outstanding shares 171560000 (171.56 Million).

LOBE SCIENCES LTD Market Cap History: 2021 to 2025

LOBE SCIENCES LTD's market capitalization history from 2021 to 2025. Data shows change from $3.11 Million to $5.01 Million (-28.35% CAGR).

LOBE SCIENCES LTD Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how LOBE SCIENCES LTD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of 6YX0 by Market Capitalization

Companies near LOBE SCIENCES LTD in the global market cap rankings as of June 19, 2026.

Key companies related to LOBE SCIENCES LTD by market ranking:

  • Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
  • Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #444 globally with a market cap of $62.63 Billion USD.
  • UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
  • Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#222 Vertex Pharmaceuticals Inc NASDAQ:VRTX $110.45 Billion $458.99
#444 Regeneron Pharmaceuticals Inc NASDAQ:REGN $62.63 Billion $607.93
#549 UCB SA BR:UCB $49.68 Billion €252.40
#573 Argen-X BR:ARGX $47.14 Billion €780.20

LOBE SCIENCES LTD Historical Marketcap From 2021 to 2025

Between 2021 and today, LOBE SCIENCES LTD's market cap moved from $3.11 Million to $ 5.01 Million, with a yearly change of -28.35%.

Year Market Cap Change (%)
2025 €5.01 Million +100.00%
2024 €2.51 Million +31.58%
2023 €1.91 Million -52.50%
2022 €4.01 Million +29.03%
2021 €3.11 Million --

End of Day Market Cap According to Different Sources

On Jun 18th, 2026 the market cap of LOBE SCIENCES LTD was reported to be:

Source Market Cap
Yahoo Finance $2.90 Million USD
MoneyControl $2.90 Million USD
MarketWatch $2.90 Million USD
marketcap.company $2.90 Million USD
Reuters $2.90 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About LOBE SCIENCES LTD

F:6YX0 Germany Biotechnology
Market Cap
$5.01 Million
€4.29 Million EUR
Market Cap Rank
#29531 Global
#2573 in Germany
Share Price
€0.03
Change (1 day)
+21.95%
52-Week Range
€0.01 - €0.04
All Time High
€0.20
About

Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouv… Read more